Authors


John H. Merey, MD

Latest:

Ophthalmologist shares his story on Holocaust Remembrance Day

John H. Merey, MD, possibly one of the last Holocaust survivors still in the practice of ophthalmology, shares his story.


Caesar K. Luo, MD, FACS, FASRS

Latest:

Searching for durable therapies for diabetic macular edema amid the pandemic

Patients’ reluctance to visit a clinic during the COVID-19 pandemic is pushing retina specialists to optimize therapy.


Albert J. Augustin, MD

Latest:

Optimizing Care For Patients With Retinal Disorders

Key takeaways from a discussion on the management of age-related macular degeneration, diabetic macular edema, and inherited retinal disease and insight regarding what to look forward to as the field advances.


Michael A. Singer, MD

Latest:

Exploring cryopreserved amniotic membrane following intravitreal injection

CAM encourages corneal healing in patients with ocular surface disease.


David Lally, MD

Latest:

Sustained-release anti-inflammatory therapy is valuable in noninfectious uveitis

Long-term sustained-release therapy pays off in management of chronic, vision-threatening disease.


Carolyn Majcher, OD, FAAO

Latest:

DR/DME: Ongoing Clinical Trials and New Diagnostic Tools

Carolyn Majcher, OD, FAAO, and Rishi Singh, MD, discuss new and upcoming clinical trials, investigational therapies, and diagnostic tools for the treatment of diabetic retinopathy and diabetic macular edema (DR/DME).


Advertorial

Latest:

Broadening the benefits of iCare EIDON retinal imaging with the new Ultra-Wide Field Module

This article is produced by iCare Finland for healthcare professionals and is not intended to provide medical advice and/or treatment guidance. This website is not country-specific and therefore may contain information which is not applicable to your country.


Fred Crawford, MD

Latest:

Successful treatment of bilateral diffuse Uveal melanocytic proliueration with plasmapheresis

Nonetheless,BDUMP remains a rare condition with fewer than 60 cases documented in literature.


Patrizia Busatto, MD

Latest:

IOL designed for AMD offers hope for patients

Examining an intraocular implant that can sharpen vision for patients as disease progresses.


Tunde Peto, MD, PhD

Latest:

Creating the best care environment for patients with diabetic eye disease

Tunde Peto, MD, PhD, discusses her presentation on providing the best virtual care for patients with diabetic eye disease at EURETINA 2021.


Mike Hennessy Sr, Founder and Chairman, MJH Life Sciences

Latest:

Saving the world: Pharmaceutical innovation in nine months

The COVID-19 vaccine, and the speed at which it was developed, is the medical breakthrough of our lifetimes.


Jean-Francois Korobelnik, MD

Latest:

Optimizing Care For Patients With Retinal Disorders

Key takeaways from a discussion on the management of age-related macular degeneration, diabetic macular edema, and inherited retinal disease and insight regarding what to look forward to as the field advances.


Jennifer Lim, MD, FARVO, FASRS

Latest:

Patient Cases Demonstrating the Application of Treat and Extend Algorithm for Faricimab in DME

Dr Jennifer Lim presents two case studies demonstrating the application of the personalized treatment interval algorithm from the YOSEMITE and RHINE clinical trials for faricimab in DME.


George Magrath, MD

Latest:

Using virtual reality mobility testing as a standardized clinical end point in inherited retinal disorders

The use of VR mazes hold an intrinsic advantage compared with physical mazes in the ability to control conditions and test various patterns with reliability, participant safety, and repeatability.


Laird Harrison

Latest:

Microaneurysm turnover predicts diabetic retinopathy progression

Micoaneurysm turnover in the early stages of diabetic retinopathy predicts how much the disease will progress, according to researchers.



Professor William Ayliffe

Latest:

Electroretinography: Out of the laboratory and into the clinic

OCT has many benefits, yet falls short of reliably diagnosing and managing retinopathies and glaucoma. ERG remains the stalwart method for this application and this article highlights how technological advancements have enabled its introduction to the clinic.


Julianne Mobilian

Latest:

ASRS 2019 Street Team: W. Lloyd Clark, MD

ICYMI: Dr. Clark breaks down the results of the PANORAMA Study


Dr David Gaucher

Latest:

Diagnosing early-stage AMD with a dark adaptation device

A dark adaptometer (AdaptDx; MacuLogix Inc) can aid in the diagnosis of early-stage, or subclinical, age-related macular degeneration before visual loss occurs and even before structural changes are observed, and adds to the information obtained from retina cameras and OCT imaging.


Steve Lenier

Latest:

Applying AI in fundus images

FDA decision changes scope of healthcare delivery; increases patient access to early detection of DR


Kamal Kishore, MD

Latest:

Nailing intravitreal implant injections

Treating diabetic macular edema (DME) has evolved from the ETDRS-style focal/grid laser being the standard of care since 1985 to the modern era of pharmacotherapy-with anti-vascular endothelial growth factor (VEGF) injections now taking center stage as primary treatment for most patients.


Adam Berger, MD

Latest:

Retina surgeon’s AMD regimen at center of Medicare fraud case

Earlier this month, a jury convicted West Palm Beach retina surgeon Solomon Melgen, MD, on 67 counts of Medicare fraud. This high-profile case hit very close to home, as myself and another retina specialist from my own community were on opposing sides of the case.



Gary D. Novack, PhD

Latest:

Novel therapies abound in pipeline

The importance of novel therapies for ocular disease is a given. However, as most novel therapies are financed by the private sector, it is fortunate that investors find ophthalmology a worthwhile investment.


Dr Zachary Bodnar

Latest:

Diagnosing and treating MacTel degenerative retinal disease

Idiopathic macular telangiectasia (MacTel) is bilateral condition characterised by ectatic capillaries of the macula and atrophy of the neurosensory retina. Familiarity with the distinctive intraretinal cavitation on SD-OCT in type 2, the most common type, is key for correct diagnosis.


Margaret Wong, MD

Latest:

Scleral buckle technique using PPV, laser photocoagulation

Scleral buckles and vitrectomy are the two main procedures used today to treat retinal detachments, with many surgeons performing a combination of the two.


Dr Andrzej Grzybowski

Latest:

Assessing the impact of FLACS on surgical outcomes

FLACS is related to an increase of anterior chamber prostaglandin and cytokines, resulting in intra-operative miosis. This can be prevented by pre-operative non-steroidal anti-inflammatory drug application. As a result of methodological problems, several studies on the association between femtosecond laser-assisted cataract surgery and cystoid macular oedema are inconclusive.


Dr Piotr Kanclerz

Latest:

Assessing the impact of FLACS on surgical outcomes

FLACS is related to an increase of anterior chamber prostaglandin and cytokines, resulting in intra-operative miosis. This can be prevented by pre-operative non-steroidal anti-inflammatory drug application. As a result of methodological problems, several studies on the association between femtosecond laser-assisted cataract surgery and cystoid macular oedema are inconclusive.


Lawrence P.L. IU

Latest:

Outer retinal layer thickness predicts visual acuity in diabetic macular oedema

Diabetes mellitus is a common health problem in developed countries, with diabetic macular oedema (DMO) being a major cause of visual loss. A variety of treatment modalities for DMO are available including laser, steroid and intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents.


Dr Peter Karth

Latest:

Diagnosing and treating MacTel degenerative retinal disease

Idiopathic macular telangiectasia (MacTel) is bilateral condition characterised by ectatic capillaries of the macula and atrophy of the neurosensory retina. Familiarity with the distinctive intraretinal cavitation on SD-OCT in type 2, the most common type, is key for correct diagnosis.

© 2024 MJH Life Sciences

All rights reserved.